The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
New onset diabetes, type 1 diabetes and COVID-19
Open accessAbstract
Background and aims New data has emerged regarding higher risk of coronavirus disease 2019 (COVID-19), and its severity and complications in patients with type 2 diabetes mellitus (T2DM). However, there is a dearth of evidence regarding type 1 diabetes mellitus (T1DM). This article explores the possibility of COVID 19 induced diabetes and highlights a potential bidirectional link between COVID 19 and T1DM. Methods A literature search was performed with Medline (PubMed), Scopus, and Google Scholar electronic databases till October 2020, using relevant keywords (COVID-19 induced diabetes; COVID-19 and type 1 diabetes; COVID-19 induced DKA; new-onset diabetes after SARS-CoV-2 infection) to extract relevant studies describing relationship between COVID-19 and T1DM. Results Past lessons and new data teach us that severe acute respiratory syndrome coronaviruses (SARS-CoV and SARS-CoV-2) can enter islet cells via angiotensin converting enzyme-2 (ACE-2) receptors and cause reversible β-cell damage and transient hyperglycemia. There have been postulations regarding the potential new-onset T1DM triggered by COVID-19. This article reviews the available evidence regarding the impact and interlink between COVID-19 and Τ1DM. We also explore the mechanisms behind the viral etiology of Τ1DM. Conclusions SARS-CoV-2 can trigger severe diabetic ketoacidosis at presentation in individuals with new-onset diabetes. However, at present, there is no hard evidence that SARS-CoV-2 induces T1DM on it’s own accord. Long term follow-up of children and adults presenting with new-onset diabetes during this pandemic is required to fully understand the type of diabetes induced by COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 1×
“angiotensin-I-VII, was found to be the functional receptor for SARSCoV-1 and -2 [36].”
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“ACE2 is abundantly present in humans in the epithelia of the lung and small intestine, which might provide possible routes of entry for the SARS-CoV-1, and -2 [37].”
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852
New-onset diabetes in Covid-19
Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2018688 · Cited by 801
Bode, B., Garrett, V., Messler, J., McFarland, R., Crowe, J., Booth, R., & Klonoff, D. C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820924469 · Cited by 766
Viral infections in type 1 diabetes mellitus — why the β cells?
Op de Beeck, A., & Eizirik, D. L. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.30 · Cited by 291
Research works printed but not linked: 64
- 2006, DIAMOND Project Group Incidence and trends of childhood type 1 diabetes worldwide 1990–1999, Diabet Med, 23, 857, 10.1111/j.1464-5491.2006.01925.x · DOI · Paper page
- Chee, 2020, Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus, Diabetes Res Clin Pract, 164, 108166, 10.1016/j.diabres.2020.108166 · DOI · Paper page
- Sardu, 2020, Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?, Diabetes Care, 43, 1408, 10.2337/dc20-0723 · DOI · Paper page
- Li, 2020, COVID-19 infection may cause ketosis and ketoacidosis, Diabetes Obes Metabol
- Apicella, 2020, COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The lancet, Diabetes & Endocrinology, 8, 782
- Reddy, 2020, Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature, Diabetes Metab Syndr, 14, 1459, 10.1016/j.dsx.2020.07.050 · DOI
- Unsworth, 2020, New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K, Diabetes Care, 10.2337/dc20-1551 · DOI · Paper page
- Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4 · DOI · Paper page
- Filippi, 2008, Viral trigger for type 1 diabetes: pros and cons, Diabetes, 57, 2863, 10.2337/db07-1023 · DOI · Paper page
- Coppieters, 2012, Virus infections in type 1 diabetes, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a007682 · DOI
- Imagawa, 2000, A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group, N Engl J Med, 342, 301, 10.1056/NEJM200002033420501 · DOI · Paper page
- Imagawa, 2003, Fulminant type 1 diabetes: a nationwide survey in Japan, Diabetes Care, 26, 2345, 10.2337/diacare.26.8.2345 · DOI · Paper page
- Sano, 2008, A case of fulminant type 1 diabetes mellitus after influenza B infection, Diabetes Res Clin Pract, 79, e8, 10.1016/j.diabres.2007.10.030 · doi:10.1016/j.diabres.2007.10.030
- Goto, 2008, A case of fulminant type 1 diabetes associated with significant elevation of mumps titers, Endocr J, 55, 561, 10.1507/endocrj.K07E-126 · DOI
- Akatsuka, 2009, A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody, Diabetes Res Clin Pract, 84, e50, 10.1016/j.diabres.2009.03.009 · DOI
- Hwang, 2010, Fulminant Type 1 diabetes mellitus associated with acute hepatitis A, Diabet Med, 27, 366, 10.1111/j.1464-5491.2010.02930.x · DOI
- Christen, 2004, A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes, J Clin Invest, 114, 1290, 10.1172/JCI200422557 · doi:10.1172/jci200422557
- Horwitz, 1998, Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry, Nat Med, 4, 781, 10.1038/nm0798-781 · DOI · Paper page
- Schulte, 2010, Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection, Viral Immunol, 23, 99, 10.1089/vim.2009.0072 · DOI
- Laitinen, 2014, Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes, Diabetes, 63, 446, 10.2337/db13-0619 · DOI · Paper page
- Oikarinen, 2014, Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes, Diabetes, 63, 655, 10.2337/db13-0620 · DOI
- Stene, 2010, Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY), Diabetes, 59, 3174, 10.2337/db10-0866 · DOI · Paper page
- Salminen, 2004, Isolation of enterovirus strains from children with preclinical Type 1 diabetes, Diabet Med, 21, 156, 10.1111/j.1464-5491.2004.01097.x · DOI
- Dahlquist, 2004, Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based casecontrol study, Diabetes Care, 27, 285, 10.2337/diacare.27.1.285 · doi:10.2337/diacare.27.1.285
- Sadeharju, 2003, Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial, Clin Exp Immunol, 132, 271, 10.1046/j.1365-2249.2003.02147.x · DOI
- Hiemstra, 2001, Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase, Proc Natl Acad Sci U S A, 98, 3988, 10.1073/pnas.071050898 · DOI · Paper page
- Honeyman, 2010, Evidence for molecular 549 mimicry between human T cell epitopes in rotavirus and pancreatic islet 550 autoantigens, J Immunol, 184, 2204, 10.4049/jimmunol.0900709 · DOI
- Bian, 2016, Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays, Diabetes, 65, 285, 10.2337/db15-0179 · DOI
- Nilsson, 2015, Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children, J Med Virol, 87, 1130, 10.1002/jmv.24127 · DOI
- Tapia, 2011, Longitudinal study 533 of parechovirus infection in infancy and risk of repeated positivity for multiple islet 534 autoantibodies: the MIDIA study, Pediatr Diabetes, 12, 58, 10.1111/j.1399-5448.2010.00658.x · DOI
- Yeung, 2011, Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies, BMJ, 342, d35, 10.1136/bmj.d35 · DOI · Paper page
- Lönnrot, 2017, Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study, Diabetologia, 60, 1931, 10.1007/s00125-017-4365-5 · DOI · Paper page
- Fignani, 2020, SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 is expressed in human pancreatic islet β-cells and is upregulated by inflammatory stress, bioRxiv
- Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabet Med, 23, 623, 10.1111/j.1464-5491.2006.01861.x · DOI · Paper page
- Pitocco, 2020, Lack of type 1 diabetes involvement in SARS-COV-2 population: only a particular coincidence?, Diabetes Res Clin Pract, 164, 108220, 10.1016/j.diabres.2020.108220 · DOI
- Fadini, 2020, Prevalence and impact of diabetes among people infected with SARS-CoV-2, J Endocrinol Invest, 43, 867, 10.1007/s40618-020-01236-2 · DOI · Paper page
- Joshi, 1999, Infections in patients with diabetes mellitus, N Engl J Med, 341, 1906, 10.1056/NEJM199912163412507 · DOI · Paper page
- Tiwari, 2011, Sepsis in diabetes: a bad duo, Diabetes Metab Syndr, 5, 222, 10.1016/j.dsx.2012.02.026 · DOI
- Carey, 2018, Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study, Diabetes Care, 41, 513, 10.2337/dc17-2131 · DOI · Paper page
- Magliano, 2015, Excess risk of dying from infectious causes in those with type 1 and type 2 diabetes, Diabetes Care, 38, 1274, 10.2337/dc14-2820 · DOI
- Wang, 2011, Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia, BMC Infect Dis, 11, 104, 10.1186/1471-2334-11-104 · DOI
- Wu, 2020, Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study, BMJ Open Diabetes Res Care, 8, 10.1136/bmjdrc-2020-001476 · DOI · Paper page
- Ebekozien, 2020, Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S, Diabetes Care, 43, e83, 10.2337/dc20-1088 · DOI
- Barron, 2020, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, The lancet Diabetes & endocrinology, 8, 813, 10.1016/S2213-8587(20)30272-2 · DOI · Paper page
- Ludvigsson, 2020, Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults, Acta Paediatr, 109, 1088, 10.1111/apa.15270 · DOI · Paper page
- Holman, 2020, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. The lancet, Diabetes & Endocrinology., 8, 823
- Salman, 2020, Hypoglycemia due to hydroxychloroquine, an uncommon association but to keep in mind, case report and review of literature, J Diabetes Metab Disord Control, 7, 6, 10.15406/jdmdc.2020.07.00193 · DOI
- Unübol, 2011, Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis, J Clin Rheumatol, 17, 46, 10.1097/RHU.0b013e3182098e1f · DOI
- Paengsai, 2019, Recommended first-line antiretroviral therapy regimens and risk of diabetes mellitus in HIV-infected adults in resource-limited settings, Open Forum Infect Dis, 6, ofz298, 10.1093/ofid/ofz298 · DOI
- Deng, 2020, Corticosteroids in diabetes patients infected with COVID-19, Ir J Med Sci, 1
- Yan, 2020, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, 367, 1444, 10.1126/science.abb2762 · DOI · Paper page
- Jin, 2020, Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms, Gut, 69, 1002, 10.1136/gutjnl-2020-320926 · DOI · Paper page
- Fan, 2020, Clinical features of COVID-19-related liver functional abnormality, Clin Gastroenterol Hepatol, 18, 1561, 10.1016/j.cgh.2020.04.002 · DOI · Paper page
- Hadi, 2020, Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members, Pancreatology, 20, 665, 10.1016/j.pan.2020.04.021 · DOI · Paper page
- Anand, 2020, Acute pancreatitis in a COVID-19 patient, Br J Surg, 107, 10.1002/bjs.11657 · DOI
- Ghosh, 2020, COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes, Diabetes & Metabolic Syndrome, Clin Res Rev
- Wang, 2020, Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia, Gastroenterology, 159, 367, 10.1053/j.gastro.2020.03.055 · DOI · Paper page
- Szatmary P, Arora A, Raraty MGT, Dunne DFJ, Baron RD, Halloran CM. Emerging phenotype of SARS-CoV2 associated pancreatitis. Gastroenterology. doi: 10.1053/j.gastro.2020.05.069. · DOI
- Ceriello, 2020, Why is hyperglycemia worsening COVID-19 and its prognosis?, Diabetes Obes Metabol, 10.1111/dom.14098 · DOI
- Rabbone, 2020, Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?, Diabetes Care, 10.2337/dc20-1321 · DOI · Paper page
- Basatemur, 2020, Paediatric critical care referrals of children with diabetic ketoacidosis during the COVID-19 pandemic, Arch Dis Child
- Kamrath, 2020, Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany, JAMA, 324, 801, 10.1001/jama.2020.13445 · DOI · Paper page
- Potier, 2020, COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes, Diabetes Metab, S1262–3636
- Kuchay, 2020, Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19, Diabetes Metab Syndr, 14, 2039, 10.1016/j.dsx.2020.10.015 · DOI
Cited by
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Wu, C.-T., Lidsky, P. V., Xiao, Y., Lee, I. T., Cheng, R., Nakayama, T., Jiang, S., Demeter, J., Bevacqua, R. J., Chang, C. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.013 · Cited by 364
COVID-19 as a trigger for type 1 diabetes
Wang, Y., Guo, H., Wang, G., Zhai, J., & Du, B. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad165 · Cited by 50
Karavanaki, K., Rodolaki, K., Soldatou, A., Karanasios, S., & Kakleas, K. (2022) · Endocrine · doi:10.1007/s12020-022-03266-7 · Cited by 20
Is Pollution the Primary Driver of Infectious Syndemics?
Singer, M. (2024) · Pathogens · doi:10.3390/pathogens13050370 · Cited by 8
“Recently, Rubino et al. [69], based on a growing body of literature on COVID-19-caused glucose dysregulation [70–74], assert “There is a bidirectional relationship between COVID-19 and diabetes.”
Background
Metadata
- Authors
- Boddu, S. K., Aurangabadkar, G., & Kuchay, M. S.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 14
- Issue
- 6
- Pages
- 2211-2217
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W3100694757
- Cited by
- 185
- References
- 8
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.